Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen

被引：5

作者：

Ibrahim, Moayed ^{[1
]}

Chen, Rebecca ^{[2
]}

Vegel, Andrew ^{[2
]}

Panse, Ketaki ^{[2
]}

Bhyravabhotla, Kshama ^{[2
]}

Harris, Kendra ^{[3
]}

Craig, Ryan ^{[4
]}

Safah, Hana ^{[1
]}

Saba, Nakhle S. ^{[1
]}

Socola, Francisco ^{[1
]}

机构：

[1] Tulane Univ, Deming Dept Med, Sect Hematol & Med Oncol, New Orleans, LA 70118 USA

[2] Tulane Univ, Deming Dept Med, New Orleans, LA 70118 USA

[3] Tulane Univ, Dept Radiat Oncol, New Orleans, LA 70118 USA

[4] Tulane Univ, Dept Pathol & Lab Med, New Orleans, LA 70118 USA

来源：

LEUKEMIA RESEARCH | 2021年 / 106卷

关键词：

GRANULOCYTIC-SARCOMA; LEUKEMIA;

D O I：

10.1016/j.leukres.2021.106583

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 16 条

[1] Myeloid Sarcoma: Presentation, Diagnosis, and Treatment [J].

Almond, L. Max ;

Charalampakis, Maria ;

Ford, Samuel J. ;

Gourevitch, David ;

Desai, Anant .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (05) :263-267

[2] Gemtuzumab Ozogamicin Therapy for Isolated Extramedullary AML Relapse after Allogeneic Hematopoietic Stem-Cell Transplantation [J].

Ando, Toshihiko ;

Mitani, Noriyuki ;

Matsunaga, Kimie ;

Nakazora, Tatsuki ;

Gondo, Toshikazu ;

Yujiri, Toshiaki ;

Tanizawa, Yukio .

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 220 (02) :121-125

[3] Gemtuzumab ozogamicin for acute myeloid leukemia [J].

Appelbaum, Frederick R. ;

Bernstein, Irwin D. .

BLOOD, 2017, 130 (22) :2373-2376

[4] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J].

Arber, Daniel A. ;

Orazi, Attilio ;

Hasserjian, Robert ;

Thiele, Jurgen ;

Borowitz, Michael J. ;

Le Beau, Michelle M. ;

Bloomfield, Clara D. ;

Cazzola, Mario ;

Vardiman, James W. .

BLOOD, 2016, 127 (20) :2391-2405

[5] Clinical implications of acute myeloid leukemia presenting as myeloid sarcoma [J].

Avni, Batia ;

Rund, Debora ;

Levin, Moshe ;

Grisariu, Sigal ;

Ben-Yehuda, Dina ;

Bar-Cohen, Sara ;

Paltiel, Ora .

HEMATOLOGICAL ONCOLOGY, 2012, 30 (01) :34-40

[6] Use of Radiation in Extramedullary Leukemia/Chloroma: Guidelines From the International Lymphoma Radiation Oncology Group [J].

Bakst, Richard L. ;

Dabaja, Bouthaina Shbib ;

Specht, Lena K. ;

Yahalom, Joachim .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (02) :314-319

[7] Myeloid Sarcoma Extramedullary Manifestation of Myeloid Disorders [J].

Campidelli, Cristina ;

Agostinelli, Claudio ;

Stitson, Richard ;

Pileri, Stefano A. .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (03) :426-437

[8] A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome [J].

Daver, N. ;

Kantarjian, H. ;

Ravandi, F. ;

Estey, E. ;

Wang, X. ;

Garcia-Manero, G. ;

Jabbour, E. ;

Konopleva, M. ;

O'Brien, S. ;

Verstovsek, S. ;

Kadia, T. ;

Dinardo, C. ;

Pierce, S. ;

Huang, X. ;

Pemmaraju, N. ;

Diaz-Pines-Mateo, M. ;

Cortes, J. ;

Borthakur, G. .

LEUKEMIA, 2016, 30 (02) :268-273

[9] Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set [J].

Goyal, G. ;

Bartley, A. C. ;

Patnaik, M. M. ;

Litzow, M. R. ;

Al-Kali, A. ;

Go, R. S. .

BLOOD CANCER JOURNAL, 2017, 7 :e592-e592

[10] Venetoclax for Refractory Myeloid Sarcoma [J].

Kanate, Abraham S. ;

Vos, Jeffrey ;

Chargualaf, Michael J. .

JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (07) :413-+

← 1 2 →